Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
After this presentation, the participant should be able to:
1. Compare and contrast the benefits and risks of providing methadone, buprenorphine or medication assisted-withdrawal during pregnancy for the mother, fetus and neonate.
2. Identify the benefits of measuring and treating neonatal opioid withdrawal using different assessment tools and medication strategies
3. Examine the different approaches for dealing with problem behaviors related to opioid addiction during pregnancy and the postpartum period.
Date: March 25, 2013
Speaker: Hendree Jones, PhD, UNC Horizons Director, Visiting Professor, Department of Obstetrics and Gynecology, UNC Chapel Hill, NC
Time: 1:00 pm – 2:00 pm ET
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reﬂect the ofﬁcial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.